Skip to content

LEXICON PHARMACEUTICALS, INC.

LXRX

CIK 0001062822

← back to feed
Revenue (TTM)
$5.71M
+440.6% YoY Q1 May 2026
Net Income (TTM)
−$35.86M
+74.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.10
+77.8% YoY Q1 May 2026
Gross Margin
96.8%
Q1 May 2026
Operating Margin
-614.8%
Q1 May 2026
Net Margin
-627.6%
Q1 May 2026
Free Cash Flow (TTM)
−$145.61M
Q1 May 2026
Cash
$38.09M
Q1 May 2026
Total Debt
$49.68M
Q1 May 2026
Shares Outstanding
444.2M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings